Navigation Links
Genomic Health to Present at Two Upcoming Investor Conferences

REDWOOD CITY, Calif., Sept. 13 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in September:

  • Dean Schorno, senior vice president of Finance, will present at the Stifel Nicolaus Healthcare Conference 2010 on Friday, September 17 at 11:30 a.m. ET in Boston; and
  • Brad Cole, Genomic Health's Chief Operating Officer and Chief Financial Officer, will present at the JMP Securities Healthcare Conference on Monday, September 27 at 11:00 a.m. ET in New York City.

To access the live and subsequently archived webcasts of the presentations, visit the Investor Relations section of Genomic Health's website at Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX(R) breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health launched its Oncotype DX colon cancer test in January 2010. As of June 30, 2010, more than 10,000 physicians in over 55 countries had ordered more than 160,000 Oncotype DX tests. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit

NOTE: The Genomic Health logo, Oncotype and Oncotype DX are trademarks or registered trademarks of Genomic Health, Inc.

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
2. J. Craig Venter Institute Hosts Genomics Education Program for DC Metro Area Teachers
3. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
4. Sirius Genomics Announces Appointment of Senior Director of Business Development
5. SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
6. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
7. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
8. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
9. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
10. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
11. Trinean Reduces Volume and Time Requirements for Genomic DNA Quantification
Post Your Comments:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: ... banks to provide their customers enhanced security to ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):